Chemistry: molecular biology and microbiology – Differentiated tissue or organ other than blood – per se – or...
Reexamination Certificate
2006-04-06
2009-10-13
Saucier, Sandra E. (Department: 1651)
Chemistry: molecular biology and microbiology
Differentiated tissue or organ other than blood, per se, or...
Reexamination Certificate
active
07601487
ABSTRACT:
A corneal storage solution which maintains cell density and cell viability of corneas stored in vitro for a period of greater than four days up to about two weeks is provided. The solution contains a buffered, balanced, nutrient and electrolyte aqueous solution, at least one colloidal osmotic agent, a phenolic antioxidant compound, a non-lactate-generating substrate, a thiol-containing compound, insulin, and at least one antibiotic. A method for in vitro storage and preservation of the viability of human corneal endothelial cells for subsequent use includes the steps of removing a cornea from an eye globe and placing the cornea in the above corneal storage solution.
REFERENCES:
patent: 4238482 (1980-12-01), Peyman
patent: 4271144 (1981-06-01), Holly
patent: 4695536 (1987-09-01), Lindstrom
patent: 4713375 (1987-12-01), Lindstrom
patent: 4844242 (1989-07-01), Chen
patent: 4873186 (1989-10-01), Chen
patent: 4886786 (1989-12-01), Lindstrom et al.
patent: 4981841 (1991-01-01), Gibson
patent: 5013714 (1991-05-01), Lindstrom
patent: 5066578 (1991-11-01), Wikman-Coffelt
patent: 5073492 (1991-12-01), Chen
patent: 5104787 (1992-04-01), Lindstrom
patent: 5166048 (1992-11-01), Soll
patent: 5204325 (1993-04-01), Lindstrom
patent: 5298487 (1994-03-01), Chen
patent: 5306711 (1994-04-01), Andrews
patent: 5326699 (1994-07-01), Torishima
patent: 5366964 (1994-11-01), Lindstrom
patent: 5405742 (1995-04-01), Taylor
patent: 5407669 (1995-04-01), Lindstrom
patent: 5589451 (1996-12-01), Wilson
patent: 5599659 (1997-02-01), Brasile
patent: 5643712 (1997-07-01), Brasile
patent: 5654266 (1997-08-01), Chen
patent: 5723281 (1998-03-01), Segall
patent: 5827641 (1998-10-01), Parenteau
patent: 6153582 (2000-11-01), Skelnik
patent: 6162642 (2000-12-01), Redbrake-Adams
patent: 6541256 (2003-04-01), Chen
patent: 6645715 (2003-11-01), Griffith
patent: 6706499 (2004-03-01), Mangnsson
patent: 6838448 (2005-01-01), Ponzin
patent: 6949335 (2005-09-01), Fahy et al.
patent: 2001/0055809 (2001-12-01), Mangat
patent: 2002/0081289 (2002-06-01), Neuhann
patent: 2002/0103222 (2002-08-01), Mangat
patent: 2002/0132220 (2002-09-01), Berens
patent: 2003/0149002 (2003-08-01), Goddard
patent: 2004/0142466 (2004-07-01), Mangat
patent: 2004/0185561 (2004-09-01), Cook
patent: 0 562 188 (1992-09-01), None
patent: 0 516 901 (1992-12-01), None
patent: 0 517 972 (1992-12-01), None
patent: 02-005859 (1990-01-01), None
patent: 02-113885 (1990-04-01), None
patent: 05-025001 (1993-02-01), None
patent: WO 97/37537 (1997-10-01), None
patent: WO 00/47040 (2000-08-01), None
Medum 199 Modified (M199):, JRH Biosciences, Product Information, Catalog No. 51312, 1 page (2005).
Wang et al., “Use of carnosine as a natural anti-senescence drug for human beings.”,Biochemistry, vol. 65(7), pp. 869-871 (2000).
Hipkiss et al., “Carnosine reacts with protein carbonyl groups: Another possible role for the anti-ageing peptide?”,Biogerontology, vol. 1(3), pp. 217-223 (2000).
Hipkiss et al., “A possible new role for the anti-ageing peptide carnosine”,CMLS Cell. Mol. Life Sci., vol. 57, pp. 747-753 (2000).
Camposampiero et al., “Cornea preservation in culture with bovine serum or chicken ovalbumin”,Cornea, vol. 22(3), pp. 254-258 (2003).
Redbrake, et al., “Correlation between glucose and lactate concentrations in the human cornea and in organ culture medium”,Klin Monatsb. Augerheilkd, vol. 213, pp. 93-96, 1 page (1998).
“Organ preservation protocols”, Catholic University of Louvain, St.—Luc University Hospital Head and Neck Oncology Progamme,Organ Preserv. 11 pages (2001).
Chen et al., “The Efficacy of Non-Lactate-Generating Metabolites as Substrates for Maintaining Donor Tissues”,Transplantation, vol. 57, No. 12, pp. 1778-1785, (1994).
Hiebert, et al., “Protective Action of Polyelectrolytes on Endothelium”,Seminars in Thrombosis and Hemostasis, vol. 17, Supplement 1, pp. 42-46 (1991).
Lindstrom, “Advances in Corneal Preservation”, Tr. Am. Ophth. Soc., Vol. LXXXVIII, pp. 555-648, (1990).
Cornea Donor Study Group, “An Evaluation of Image Quality and Accuracy of Eye Bank Measurement of Donor Cornea Endothelial Cell Density in the Specular Microscopy Ancillary Study”, American Academy of Ophthalmology,Opthamology, vol. 112, No. 31, pp. 431-440 (2005).
Middleton, Jr. et al., “The Effects of Plant Flavonoids on Mammalian Cells: Implications for Inflammation, Heart Disease, and Cancer”,Pharmacol Reviews, vol. 52, pp. 673-751 (2000).
Zeng et al., “Morin hydrate: a better protector than purpurogallin of corneal endothelial cell damage induced by xanthine oxidase and SIN-1”,Curr. Eye Res., vol. 17, pp. 149-152 (1998).
Fang et al., “Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock”,Life Sciences, vol. 74, pp. 743-756 (2003).
Hull et al., “Dextran uptake into, and loss from, corneas stored in intermediate-term preservative”,Investigative Ophthalmology, vol. 15, No. 8, pp. 663-666 (1976).
Ediriwickrema et al., “Natural killer cell-dependent immunoglobulin G2a anti-bovine serum albumin (BSA) response elicited by high molecular weight dextran-BSA conjugates associated with dextran-mediated macrophage-natural killer cell interaction”,Immunology, vol. 101, pp. 474-483 (2000).
Halberstadt et al., “Corneal Cryopreservation with Dextran”,Cryobiology, vol. 43, pp. 71-80 (2001).
Jagodzinski et al., “The effect of high molecular weight dextran sulfate on the production of interleukin-8 in monocyte cell culture”,Biomed Pharmacother, vol. 56, pp. 254-257 (2002).
Chen et al., “Efficacy of Media Enriched with Nonlactate-Generating Substrate for Organ Preservation: In Vitro and Clinical Studies Using the Cornea Model1,2”,Transplantation, vol. 67(6), pp. 800-808 (1999).
Nakamura et al, “Protective Effect of D-β-Hydroxybutyrate on Corneal Epithelia in Dry Eye Conditions through Suppression of Apoptosis”,Investigative Ophthamology&Visual Science, vol. 44, No. 11, pp. 4682-4688 (2003).
Rocha et al., “Identification of Insulin in the Tear Film and Insulin Receptor and IGF-I Receptor on the Human Ocular Surface”,Investigative Ophthamology&Visual Science, vol. 43, No. 4, pp. 963-967 (2002).
Imanishi et al., “Growth Factors: Importance in Wound Healing and Maintenance of Transparency of the Cornea”,Progress in Retinal and Eye Research, vol. 19, No. 1, pp. 113-129 (2000).
Chen et al., “Efficacy of Organ Preservation Media Enriched with Nonlactate-Generating Substrate for Maintaining Tissue Viability: A Transplantation Study”,Transplantation, vol. 63(5), pp. 656-663 (1997).
Chin Fook et al., “The Prevention of Autolysis of Stored Cornea Using Steroid as a Lysosome Membrane Stabilizer”,Canad. J. Ophthal., vol. 10, pp. 482-486 (1975).
Travkin et al., “Effect of Antioxidants with Different Antiradical Activity on Cornea Preservation”, Biofizika, vol. 21(6), pp. 1064-1066 (1976).
Basu et al., “The Prevention of Autolysis in Stored Corneas by Lysosome Stabilization. A Histochemical Study”,Canad. J. Ophthal., vol. 12, pp. 48-53 (1977).
Spencer et al., “Factors in the Survival of Stored Corneas”,Canad. J. Ophthal., vol. 12, pp. 123-127 (1977).
Basu et al., “Can Steroid Reduce Endothelial Damage in Stored Corneas? Effect on Cell Viability and Ultrastructure”,Canad. J. Ophthal., vol. 13, pp. 31-38 (1978).
Liao et al., “Biochemical Analysis of the Cornea Stored in Steroid Medium”,Canad. J. Ophthal., vol. 14, pp. 274-280 (1979).
Hull et al., “Corneal Endothelial Cell Function after Storage in MK Medium and Hydrocortisone”,Canad. J. Ophthal., vol. 14, pp. 114-116 (1979).
Basu et al., “Damage to Corneal Endothelial Cells by Lysosomal Enzymes in Stored Human Eyes”,Canad. J. Ophthal., vol. 15, pp
Ruiz-White Inez A.
Smith Teresita M.
Soll David B.
Cleo Cosmetic and Pharmaceutical Co., LLC
Panitch Schwarze Belisario & Nadel LLP
Saucier Sandra E.
LandOfFree
Composition using HMW dextran and method for in vitro... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition using HMW dextran and method for in vitro..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition using HMW dextran and method for in vitro... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107744